54 employees
CDR-Life AG is a biotech company that develops innovative therapeutic antibody fragments with a focus on immuno-oncology.
2017
$76M
from 3 investors over 3 rounds
CDR-Life Inc. raised $76M on April 13, 2022
Investors: Omega Funds, RA Capital Management, L.P. and JEITO